by Mrudula Kulkarni

3 minutes

Enhanc3D Genomics Launches 3D Multi-Omic Solutions to Transform Drug Discovery

From News from the Startup World | Pg 16

Enhanc3D Genomics Launches 3D Multi-Omic Solutions to Transform Drug Discovery
0

0

Read in FlipBook

Enhanc3D Genomics has unveiled a groundbreaking suite of integrated multi-omics solutions designed to revolutionize drug discovery and development. Leveraging the company’s proprietary 3D genomics platform and extensive multi-omics analysis, these new offerings provide a comprehensive end-to-end solution to support informed decision-making at every stage of the drug development process.

At the core of the platform is patented Promoter Capture Hi-C technology, which enables the creation of high-resolution, genome-wide regulatory maps. These maps capture interactions between promoters and regulatory regions, delivering unparalleled insights into genomic activity. By integrating this data with the 3D Multi-Omic Atlas, a vast repository of multi-omic data across human cell types, the platform uncovers deep insights into disease mechanisms and therapeutic opportunities, paving the way for precision-driven drug discovery./..

Comment your thoughts

12 Grids

Feb-Mar Edition

Navigating the Digital Frontier

Read More
12 Grids

Navigating the Digital Frontier

FEATURING

    • Global Industry Trends & Insights
    • Global Events & Conferences
    • Market Insights & Trends
    • "In Talks With Leadership" featuring Dr. Ashok Kumar Bhattacharya
    • SMART Practices to Take Assistance of Generative AI to Respond to FDA Warnings 
Read Now
12 Grids

Navigating the Digital Frontier

FEATURING

    • Global Industry Trends & Insights
    • Global Events & Conferences
    • Market Insights & Trends
    • "In Talks With Leadership" featuring Dr. Ashok Kumar Bhattacharya
    • SMART Practices to Take Assistance of Generative AI to Respond to FDA Warnings 
12 Grids

Feb-Mar Edition

Navigating the Digital Frontier

Read More
12 Grids

Navigating the Digital Frontier

FEATURING

    • Global Industry Trends & Insights
    • Global Events & Conferences
    • Market Insights & Trends
    • "In Talks With Leadership" featuring Dr. Ashok Kumar Bhattacharya
    • SMART Practices to Take Assistance of Generative AI to Respond to FDA Warnings 
Read Now

Other Articles from Magazine

12 Grids

Merck's WELIREG® Gains Priority FDA Review for Rare Tumors

Pg 14

12 Grids

Roche’s PATHWAY HER2 Test Gains FDA Approval For HER2-Ultralow Breast Cancer

Pg 14

12 Grids

Telix Receives European Approval for Prostate Cancer Imaging Agent

Pg 14

12 Grids

PM Modi Addresses Completion Of Indian Genome Project, Boosting Healthcare And Precision

Pg 15